IL1B and pericarditis: Moreover, the outcome of Anakinra—Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP) study showed that anakinra, a recombinant IL-1 Ra, effectively reduce the risk of recurrence in pericarditis patients with colchicine- resistant (80).